Comparative analysis of the SARS coronavirus genome: A good start to a long journey

Lancet

Volumn 361, Issue 9371, 2003, Pages 1756-1757

  Brown, Earl G ^a   Tetro, Jason A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN; VIRUS RNA;

CANADA; CELL ASSAY; CHINA; CLINICAL FEATURE; CORONAVIRUS; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN; IMMUNITY; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MUTATION; MYALGIA; NONHUMAN; NOTE; OPEN READING FRAME; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SARS CORONAVIRUS; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SORE THROAT; VERO CELL; VIRAL GENETICS; VIRUS EXAMINATION; VIRUS GENOME; VIRUS TRANSMISSION; WATER CONTAMINATION; ZOONOSIS;

EID: 0038101477     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13444-7     Document Type: Note

References (14)

1. Luk J., Gross P., Thompson W.W. Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis. 33:2001;1375-1378.
2. World Health Organization. Hospital infection control guidance for severe acute respiratory syndrome (SARS). April 24, 2003: http://www.who.int/csr/sars/infectioncontrol/en/ (accessed May 2, 2003).
3. Peiris J.S.M., Lai S.T., Poon L.L.M., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361:2003;1319-1325.
4. Ksiazek T.G., Erdman D., Goldsmith C.S., et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 348:2003;1953-1966.
5. World Health Organization. Update 31: coronavirus never before seen in humans is the cause of SARS. April 16, 2003: http://www.who.int/csr/sarsarchive/2003_04_16/en/ (accessed May 2, 2003).
6. Lai M.M.C., Holmes K.V. Coronaviridae: the viruses and their replication. Knipe D.M., Howley P.M. Fields virology. 4th edn:2001;1163-1186 Lippincott Williams & Wilkins, London.
7. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003: http://content.nejm.org/cgi/content/abstract/NEJMoa030747v2 (accessed May 6, 2003).
8. Rota PA, Oberste MS, Monroe SS. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003: http://www.sciencemag.org/cgi/rapidpdf/1085952v1.pdf (accessed May 6, 2003).
9. Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003: http://www.sciencemag.org/cgi/rapidpdf/1085953v1.pdf (accessed May 6, 2003).
10. Bush R.M., Smith C.B., Cox N.J., Fitch W.M. Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci USA. 97:2000;6974-6980.
11. Ewald P.W. The evolution of virulence and emerging diseases. J Urban Health. 75:1998;480-491.
12. Brown E.G., Liu H., Kit L.C., Baird S., Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci USA. 98:2001;6883-6888.
13. Seo S.H., Hoffmann E., Webster R.G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med. 8:2002;950-954.
14. Fields B.N. AIDS: time to turn to basic science. Nature. 369:1994;95-96.